- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.06. | Acutus Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.05. | Acutus Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 16.05. | NSE - Acutus Medical, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
| 15.05. | Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. from The Nasdaq Stock Market | 238 | GlobeNewswire (Europe) | NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better Therapeutics, Inc. Better Therapeutics, Inc.'s securities were suspended... ► Artikel lesen | |
| 09.05. | Acutus Medical delisted from Nasdaq market due to non-compliance | 2 | MassDevice | ||
| 06.05. | Why Is Acutus Medical (AFIB) Stock Down 41% Today? | 5 | InvestorPlace | ||
| 03.05. | Acutus Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 01.04. | Acutus Medical GAAP EPS of -$2.81, revenue of $7.2M | 1 | Seeking Alpha | ||
| 01.04. | Acutus Medical, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 01.04. | Acutus Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.02. | Acutus Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.11.23 | Acutus Medical, Inc.: Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring | 272 | GlobeNewswire (Europe) | CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), today announced a realignment of resources and corporate restructuring. Scott Huennekens... ► Artikel lesen | |
| 08.11.23 | Acutus Medical, Inc.: Acutus Medical Reports Third Quarter 2023 Financial Results | 180 | GlobeNewswire (Europe) | CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB) today reported results for the third quarter of 2023. Recent Highlights: Third quarter... ► Artikel lesen | |
| 02.11.23 | Acutus Medical, Inc.: Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 163 | GlobeNewswire (Europe) | CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias... ► Artikel lesen | |
| 02.10.23 | Acutus Medical, Inc.: Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 187 | GlobeNewswire (Europe) | CARLSBAD, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias... ► Artikel lesen | |
| 07.08.23 | Acutus Medical, Inc.: Acutus Medical Reports Second Quarter 2023 Financial Results | 223 | GlobeNewswire (Europe) | CARLSBAD, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias... ► Artikel lesen | |
| 01.08.23 | Acutus Medical, Inc.: Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 226 | GlobeNewswire (Europe) | CARLSBAD, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 8,562 | -0,83 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | PURCHASE, NY, July 08, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to two new employees.... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,083 | -3,02 % | Breaking News: NuGen Medical - unfassbarer Rekordauftrag! | ||
| EMEIS | 13,230 | +1,21 % | emeis: Growth in Revenue in First-Half 2024 at €2,772 Million (Up 9.2%) | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half... ► Artikel lesen | |
| ORGANON | 20,250 | -0,98 % | Organon & Co.: Europäische Arzneimittel-Agentur (EMA) validiert Einreichungen von Henlius und Organon für den Prolia und Xgeva (Denosumab) Biosimilar-Kandidaten HLX14 | Shanghai Henlius Biotech, Inc. (2696.HK) und Organon (NYSE: OGN) gaben heute bekannt, dass die Europäische Arzneimittel-Agentur (EMA) die Zulassungsanträge (MAAs) für HLX14, einen Prolia und Xgeva... ► Artikel lesen | |
| UNIDOC HEALTH | 0,426 | -0,47 % | UniDoc Health Corp.: UniDoc Receives Purchase Order from HP Inc. for 10 AI-Equipped H3 Health Cubes | -- eHealth solution to be deployed in Europe
VANCOUVER, BC, June 17, 2024 /PRNewswire/ - UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) ("UniDoc," or the "Company"), an innovator in... ► Artikel lesen | |
| NANO-X IMAGING | 8,590 | +9,29 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| BUTTERFLY NETWORK | 1,065 | -2,29 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
| CARMAT | 2,600 | +0,58 % | CARMAT accelerates its sales momentum and reiterates its confidence in its development outlook | 20 implants of the Aeson artificial heart performed in the first half of 2024
Pace of 4 implants per month in the second quarter
Half-year sales at €3.2 million, higher than the... ► Artikel lesen | |
| GOODRX | 8,850 | +1,26 % | Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira | First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18, 2024 /PRNewswire/ -- Boehringer Ingelheim and GoodRx (Nasdaq: GDRX),... ► Artikel lesen | |
| JOINT CORP | 14,220 | +4,33 % | The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results | ||
| HYPERFINE | 1,170 | +1,74 % | Hyperfine, Inc. - 8-K, Current Report | ||
| PROGYNY | 29,140 | +1,89 % | Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report | ||
| MIMEDX | 7,760 | +0,65 % | MiMedx Group, Inc: MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature - Scientific Reports | ||
| PROCEPT BIOROBOTICS | 61,85 | -3,96 % | Procept Biorobotics: Point72 Europe London LLP hat 123800 Aktien dazugekauft! | Medizintechnik-Unternehmen mit 58%-Halbjahresrallye bei Procept Biorobotics (PRCT) Immer noch rote Zahlen, aber viel Potenzial! Procept Biorobotics (PRCT) - ISIN US74276L1052 Rückblick: Das Medizintechnik-Unternehmen... ► Artikel lesen | |
| OUTSET MEDICAL | 3,740 | +0,81 % | Outset Medical Reports First Quarter 2024 Financial Results | SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity... ► Artikel lesen |
ACUTUS MEDICAL INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,090 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACUTUS MEDICAL INC finden Sie auf Wallstreet Online.
